Live Breaking News & Updates on Discuss Results|Page 2

Stay updated with breaking news from Discuss results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Immutep Announces Compelling Clinical Results from Phase II Trial Utilizing its First-in-Class Soluble LAG-3 Protein, Eftilagimod Alpha, in 1st Line NSCLC at SITC 2022 Annual Meeting

Immutep Announces Compelling Clinical Results from Phase II Trial Utilizing its First-in-Class Soluble LAG-3 Protein, Eftilagimod Alpha, in 1st Line NSCLC at SITC 2022 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , New South Wales , Immutepceo Marc Voigt , Wadet Iams , Frederic Triebel , Tim Mccarthy , Immutep Limited , American Society Of Clinical Oncology , Society Of Immunotherapy Cancer , Drug Administration , Vanderbilt Ingram Cancer Center Division Of Hematology Oncology , Merck Co Inc , Merck Sharp Dohme , Wall Street , Progressionfree Survival , Discuss Results , Annual Society , Assistant Professor , Vanderbilt Ingram Cancer Center Division , American Society , Clinical Oncology , Annual Meeting , Proportion Score , Fast Track , Tumor Type , Overall Response Rates ,

KINGSWAY TO REPORT FINANCIAL RESULTS FOR THIRD QUARTER 2022 ON NOVEMBER 10, 2022

/PRNewswire/ - (NYSE: KFS) - Kingsway Financial Services Inc. ("Kingsway" or the "Company") today announced that it will report financial results for the three. ....

United States , York Stock Exchange , New York Stock Exchange , Kingsway Financial Services Inc , Conference Call , Discuss Results , Financial Services , Participant Access Code , Webcast Link , Kingsway Financial Services Inc ,

KINGSWAY TO REPORT FINANCIAL RESULTS FOR THIRD QUARTER 2022 ON NOVEMBER 10, 2022

/PRNewswire/ - (NYSE: KFS) - Kingsway Financial Services Inc. ("Kingsway" or the "Company") today announced that it will report financial results for the three. ....

United States , York Stock Exchange , New York Stock Exchange , Kingsway Financial Services Inc , Conference Call , Discuss Results , Financial Services , Participant Access Code , Webcast Link ,

Ocular Therapeutix™ Announces Interim 7-month Data from U.S. Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet AMD

Ocular Therapeutix™ Announces Interim 7-month Data from U.S. Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet AMD
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Dilsher Dhoot , Scott Corning , Rabia Gurses Ozden , Antony Mattessich , Donald Notman , Peterk Kaiser , Chris Brinzey , Retinal Pharmaceuticals Market , Cleveland Clinic Lerner College Of Medicine , American Academy Of Ophthalmology , Ophthalmology Research , Ocular Therapeutix Inc , Exchange Commission , Well Tolerated , Favorable Safety Profile , Drug Related Ocular , Systemic Serious Adverse Events , Aflibercept Treated , Subjects Were Rescue Free , Discuss Results , American Academy , Meeting Subspecialty Day , Chief Executive , Rescue Free Rates , Australia Based Phase ,

Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences to Host Conference Call and Webcast to Discuss Results for the Fourth Quarter and Full Year 2021 and Corporate Update

Investegate announcements from atai Life Sciences, atai Life Sciences to Host Conference Call and Webcast to Discuss Results for the Fourth Quarter and Full Year 2021 and Corporate Update ....

New York , United States , San Diego , City Of , United Kingdom , Camilla Dormer , Exchange Commission , Life Sciences To Host Conference Call , Life Sciencesnv Nasdaq , Life Sciences , Host Conference Call , Discuss Results , Fourth Quarter , Full Year , Private Securities Litigation Reform Act , Investegate Announcements , Investegate Company Announcements , Atai Life Sciences , Lobenewswire And Globenewswire ,